|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Selling, general, and administrative | |||||
| Research and development costs | |||||
| Amortization of intangible assets | |||||
| Impairment of indefinite-lived intangible assets | |||||
| Acquisition and restructuring costs | |||||
| Related party acquisition and management fee costs | |||||
| Impairment of goodwill | |||||
| Restructuring costs | |||||
| Loss on sale of assets | |||||
| Other operating expense (income) | |||||
| Total operating expense | |||||
| Operating income | |||||
| Change in fair value of warrant liability | |||||
| Change in fair value of earn-out liability | |||||
| Loss (gain) on early extinguishment of debt | |||||
| Interest expense, net | |||||
| Total non-operating expense | |||||
| Income (loss) before income taxes | |||||
| Income tax expense (benefit) | |||||
| Net income (loss) | |||||
| Comprehensive income (loss): | |||||
| Pension liability gain | |||||
| Foreign currency translation adjustment | |||||
| Total other comprehensive income (loss) | |||||
| Total comprehensive income (loss) | |||||
| Common Share Data: | |||||
| Weighted average common shares outstanding - basic (in shares) | |||||
| Weighted average common shares outstanding - diluted (in shares) | |||||
| Basic net income (loss) per share ((in usd per share)) | |||||
| Diluted net income (loss) per share (in usd per share) | |||||
Loading...